retatrutide dosing clinical trials Retatrutide—A Game Changer in Obesity Pharmacotherapy Will Reta Rewrite Obesity? -

Perrini S, Giorgino F

Long-term follow-up data from cardiovascular outcomes trials indicate that any early increase in retinopathy events tends to plateau over time, and the overall trajectory of retinal health may ultimately be favorable due to sustained improvements in glycemic control

GLP-1s for Psoriasis Because this was an observational study and not a randomized trial, researchers caution that more research is needed before healthcare practitioners can safely prescribe GLP-1s to treat psoriasis itself

Retatrutide remains a developing therapy

cross-trial comparisons are therefore unreliable and should be interpreted with caution

The Role of Technology in Tracking Progress and Outcomes Technology is a valuable ally in weight management with GLP-1 therapies